♦Mesna

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Mesna

♦Mesna (mes’-na) Mesnex Pregnancy Category B Mechanism of Action Converted to its metabolite, mesna disulphide, which in the kidneys then is converted to the free thiol, mesna. The free thiol…

read more

♦6-Mercaptopurine

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦6-Mercaptopurine

♦6-Mercaptopurine (mer-kap-toe-pyoor’-een) Purinethol Pregnancy Category D Mechanism of Action Cell cycle-specific (S phase) purine antagonist antimetabolite that inhibits RNA and DNA synthesis. Indications Acute lymphocytic leukemia, acute myelocytic leukemia, acute…

read more

♦Melphalan

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Melphalan

♦Melphalan (mel’-fa-lan) Alkeran Pregnancy Category D Mechanism of Action Cell cycle-nonspecific alkylating agent that alkylates and impairs DNA replication, causing cell lysis. Indications Ovarian carcinoma; multiple myeloma; bone marrow transplant…

read more

♦Megestrol Acetate

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Megestrol Acetate

♦Megestrol Acetate (me-jess’-trole) Megace Pregnancy Category X Mechanism of Action Synthetic derivative of the naturally occurring steroid hormone progesterone with an unknown mechanism of anti-neoplastic activity. Indications Breast carcinoma, endometrial…

read more

♦Medroxyprogesterone Acetate

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Medroxyprogesterone Acetate

♦Medroxyprogesterone Acetate (me-drox-ee-proe-jess’-te-rone) Amen, Curretab, Provera, Depo-Provera Pregnancy Category X Mechanism of Action A progestin that promotes differentiation and maintenance of the endometrium, inhibits growth of sensitive malignancies, prevents ovulation…

read more

♦Mechlorethamine Hydrochloride

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Mechlorethamine Hydrochloride

♦Mechlorethamine Hydrochloride (me-klor-eth’-a-meen) Mustargen, nitrogen mustard Pregnancy Category D Mechanism of Action Cell cycle-nonspecific alkylating agent that causes abnormal base pairing of guanine and thymine, DNA cross-linking, and impaired RNA…

read more

♦Lomustine

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Lomustine

♦Lomustine (loe-mus’-teen) CCNU, CeeNu Pregnancy Category D Mechanism of Action Nitrosourea alkylating agent that prevents alkylation of DNA and RNA, which inhibits DNA, RNA, and protein synthesis. Indications Brain tumors,…

read more

♦Levamisole

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Levamisole

♦Levamisole (lev-am’-ih-sole) Ergamisol Pregnancy Category C Mechanism of Action Mediates the potentiation of monocyte, macrophage, T-lymphocyte, and antibody production. Indications Combined with 5-fluorouracil for patients with Duke’s C resected colon…

read more

♦Leuprolide

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Leuprolide

♦Leuprolide (loo-proe’-lide) Lupron, Lupron Depot, Lupron Depot-Ped Pregnancy Category X Mechanism of Action GnRH agonist that binds to gonadotrophin-releasing hormone cell surface receptors in the pituitary. Indications Palliative treatment of…

read more

♦Leucovorin Calcium

Jul 20, 2016 by in ONCOLOGY Comments Off on ♦Leucovorin Calcium

♦Leucovorin Calcium (loo-koh-vor’-in) Citrovorum factor, folinic acid Pregnancy Category C Mechanism of Action Essential for purine and DNA synthesis; bypasses the inhibitor action of folic acid antagonists. Indications ♦ Folinic…

read more
Get Clinical Tree app for offline access